Terms: = Thyroid cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB
168 results:
1. [cancer incidence and mortality in China, 2022].
Zheng RS; Chen R; Han BF; Wang SM; Li L; Sun KX; Zeng HM; Wei WW; He J
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):221-231. PubMed ID: 38468501
[No Abstract] [Full Text] [Related]
2. Statistics of Rare Events.
Proschan MA; Kherabi Y
NEJM Evid; 2024 Jan; 3(1):EVIDe2300303. PubMed ID: 38320520
[TBL] [Abstract] [Full Text] [Related]
3. A meta-analysis of total thyroidectomy and lobectomy outcomes in papillary thyroid microcarcinoma.
Bi J; Zhang H
Medicine (Baltimore); 2023 Dec; 102(50):e36647. PubMed ID: 38115346
[TBL] [Abstract] [Full Text] [Related]
4. Constructing a nomogram based on the distribution of thyroid nodules and suspicious lateral cervical lymph nodes in fine-needle aspiration biopsies to predict metastasis in papillary thyroid carcinoma.
Liu SQ; Feng JW; Yan ZT; Xing XX; Jiang WY; Jiang Y; Qian F; Xing W
Front Endocrinol (Lausanne); 2023; 14():1242061. PubMed ID: 38089614
[TBL] [Abstract] [Full Text] [Related]
5. Charcot neuroarthropathy in persons with diabetes: It's time for a paradigm shift in our thinking.
Wukich DK; Frykberg RG; Kavarthapu V
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3754. PubMed ID: 38069459
[TBL] [Abstract] [Full Text] [Related]
6. Characterization of the genomic alterations in poorly differentiated thyroid cancer.
Lee Y; Moon S; Seok JY; Lee JH; Nam S; Chung YS
Sci Rep; 2023 Nov; 13(1):19154. PubMed ID: 37932340
[TBL] [Abstract] [Full Text] [Related]
7. Risk-stratified Distant Metastatic thyroid cancer with Clinicopathological Factors and BRAF/TERT Promoter Mutations.
Cheng X; Zhou Y; Xu S; Yu H; Wu J; Bao J; Zhang L
Exp Clin Endocrinol Diabetes; 2023 Nov; 131(11):577-582. PubMed ID: 37922948
[TBL] [Abstract] [Full Text] [Related]
8. Development and validation of a nomogram for predicting the early death of anaplastic thyroid cancer: a SEER population-based study.
Cui H; Wang R; Zhao X; Wang S; Shi X; Sang J
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16001-16013. PubMed ID: 37689588
[TBL] [Abstract] [Full Text] [Related]
9. Clinical characteristics and prognosis of postpartum breast cancer.
Paik PS; Choi JE; Lee SW; Lee YJ; Kang YJ; Lee HJ; Bae SY;
Breast Cancer Res Treat; 2023 Nov; 202(2):275-286. PubMed ID: 37542632
[TBL] [Abstract] [Full Text] [Related]
10. Integrating US-guided FNAB, BRAF
Ma N; Tian HY; Yu ZY; Zhu X; Zhao DW
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5565-5574. PubMed ID: 37540271
[TBL] [Abstract] [Full Text] [Related]
11. Generalizability and Diagnostic Performance of AI Models for thyroid US.
Xu W; Jia X; Mei Z; Gu X; Lu Y; Fu CC; Zhang R; Gu Y; Chen X; Luo X; Li N; Bai B; Li Q; Yan J; Zhai H; Guan L; Gong B; Zhao K; Fang Q; He C; Zhan W; Luo T; Zhang H; Dong Y; Zhou J;
Radiology; 2023 Jun; 307(5):e221157. PubMed ID: 37338356
[TBL] [Abstract] [Full Text] [Related]
12. The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients.
Mauguen A; Grewal RK; Augensen F; Abusamra M; Mahajan S; Jayaprakasam VS; Osborne J; Haque S; Wong BZY; Ghossein RA; Fagin J; Schӧder H; Tuttle RM; Ho A; Humm JL; Larson SM
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):2971-2983. PubMed ID: 37171634
[TBL] [Abstract] [Full Text] [Related]
13. Cardiovascular and thyroid Late Effects in Pediatric Patients With Hodgkin Lymphoma Treated With ABVD Protocol.
Ali N; Selim M; Salah Z; El Nabarawy NM; Hussein H; Sidhom I
J Pediatr Hematol Oncol; 2023 May; 45(4):e455-e463. PubMed ID: 36898022
[TBL] [Abstract] [Full Text] [Related]
14. Clinical, cytological and ultrasonographic features of incidental thyroid cancer in a hospital-based study in vietnam.
Nguyen BQ; Tran HT; Nguyen HTT; Nguyen TX; Nguyen TTH; Nguyen TN; Vu HTT
Endocrinol Diabetes Metab; 2023 May; 6(3):e415. PubMed ID: 36896571
[TBL] [Abstract] [Full Text] [Related]
15. A prospective cohort study of infertility and cancer incidence.
Wang S; Gaskins AJ; Farland LV; Zhang D; Birmann BM; Rich-Edwards JW; Wang YX; Tamimi RM; Missmer SA; Chavarro JE
Fertil Steril; 2023 Jul; 120(1):134-142. PubMed ID: 36849034
[TBL] [Abstract] [Full Text] [Related]
16. Features of mixed medullary thyroid tumors: An NCDB analysis of clinicopathologic characteristics and survival.
Sandilos G; Lou J; Butchy MV; Gaughan JP; Reid L; Spitz FR; Beninato T; Moore MD
Am J Surg; 2023 Jul; 226(1):53-58. PubMed ID: 36775791
[TBL] [Abstract] [Full Text] [Related]
17. Alcoholic liver disease in relation to cancer incidence and mortality: Findings from a large, matched cohort study in South Korea.
Tran TPT; Han M; Luu NM; Oh JK
Cancer Med; 2023 Apr; 12(7):8754-8766. PubMed ID: 36653955
[TBL] [Abstract] [Full Text] [Related]
18. The Spectrum of thyroid Nodules at Kinshasa University Hospital, Democratic Republic of Congo: A Cross-Sectional Study.
Bukasa JK; Bayauli-Mwasa P; Mbunga BK; Bangolo A; Kavula W; Mukaya J; Bindingija J; M'Buyamba-Kabangu JR
Int J Environ Res Public Health; 2022 Dec; 19(23):. PubMed ID: 36498276
[TBL] [Abstract] [Full Text] [Related]
19. Serum IgG4 level for malignancy prediction in indeterminate thyroid nodules among patients with or without autoimmune thyroid disease.
Elshaer RK; Halawa MR; Ahmed IZ; Aboelezz NF; Mohamed NR; Bahaa Eldin AM
Egypt J Immunol; 2022 Oct; 29(4):156-162. PubMed ID: 36208044
[TBL] [Abstract] [Full Text] [Related]
20. thyroid Oncocytic (Hürthle Cell) Nodules With Longitudinal Nuclear Grooves: Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 15 Cases.
Suster D; Mackinnon AC; Suster S
Arch Pathol Lab Med; 2023 Jun; 147(6):684-691. PubMed ID: 36084253
[TBL] [Abstract] [Full Text] [Related]
[Next]
